Epidemiological survey of bacterial resistance in upper respiratory tract infections in Italy

被引:13
作者
Cornaglia, G [1 ]
Fontana, R [1 ]
机构
[1] Univ Verona, Dept Pathol, Microbiol Sect, I-37134 Verona, Italy
关键词
antimicrobial resistance; epidemiology; upper respiratory tract infections;
D O I
10.1016/S0924-8579(00)00255-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The vast majority of infections in the upper airways are caused by four bacterial species;, in Italy as elsewhere, antibiotics resistant strains are emerging. Enzymatic resistance to beta -lactams in Haemophilus influenzae is becoming more important and affects 15% of isolates. On the other hand less than 0.3% of H. influenzae strains are fluoroquinolone-resistant. The number of beta -lactamase producing Moraxella catarrhalis strains in Italy has been thought to be lower than in other countries, but recent studies suggest 90% of strains are positive, a figure similar to figures reported in the international literature. The most recent data estimate high-level resistance to penicillin in pneumococci to be around 5%, but varies greatly in different geographical areas and with the different origins of the isolates. In spite of the low incidence of penicillin-resistant strains, the most recent figures for macrolide-resistance in Streptococcus pneumoniae range from 26.4 to 31.7%. More than 3 years after the dramatic increase in erythromycin-resistant Streptococcus pyogenes, the resistance levels in Italy are still among the highest in the world. Unlike the experience in other countries, resistance is often related not to the active efflux of antibiotic from the bacterial cell but to ribosomal methylation, thus affecting not only 14- and 15-membered macrolides, but also 16-membered compounds and lincosamides. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 29 条
[1]   Resistance patterns of Haemophilus influenzae [J].
Acar, JF .
JOURNAL OF CHEMOTHERAPY, 1999, 11 :44-50
[2]  
*ALEX PROJ GROUP, 1999, J CHEMOTHER S1, V11, P5
[3]  
Baquero F, 1997, J CHEMOTHERAPY, V9, P29
[4]  
BAQUERO F, 1997, BUGS DRUGS EUROPE LA
[5]   Streptococcus pyogenes erythromycin resistance in Italy [J].
Bassetti, M ;
Mantero, E ;
Gatti, G ;
Di Biagio, A ;
Bassetti, D .
EMERGING INFECTIOUS DISEASES, 1999, 5 (02) :302-303
[6]  
Bronzwaer SLAM, 1998, BRIT MED J, V317, P615
[7]   High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: An epidemiological and molecular study [J].
Cocuzza, CE ;
Mattina, R ;
Mazzariol, A ;
Orefici, G ;
Rescaldani, R ;
Primavera, A ;
Bramati, S ;
Masera, G ;
Parizzi, F ;
Cornaglia, G ;
Fontana, R .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (04) :371-378
[8]  
Cornaglia G, 1999, REV MED MICROBIOL, V10, P245
[9]  
CORNAGLIA G, 1993, BINARY, V5, P159
[10]  
CORNAGLIA G, 1999, NEW CONSIDERATIONS M, P250